Maravai Lifesciences Holdings, Inc. (MRVI)
3.93
+0.08
(+2.08%)
USD |
NASDAQ |
Jan 09, 16:00
3.94
+0.01
(+0.25%)
After-Hours: 20:00
Maravai Lifesciences Holdings Shareholders Equity (Quarterly): 245.44M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Rockwell Medical, Inc. | 37.02M |
| AdaptHealth Corp. | 1.617B |
| CEL-SCI Corp. | 15.96M |
| AIM ImmunoTech, Inc. | -6.077M |
| IGC Pharma, Inc. | 8.092M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 849.19M |
| Total Liabilities (Quarterly) | 417.33M |
| Debt to Equity Ratio | 1.499 |
| Current Ratio | 5.292 |
| Net Debt Paydown Yield | 9.34% |